182 related articles for article (PubMed ID: 30805946)
1. Methadone dosing strategies in preterm neonates can be simplified.
van Donge T; Samiee-Zafarghandy S; Pfister M; Koch G; Kalani M; Bordbar A; van den Anker J
Br J Clin Pharmacol; 2019 Jun; 85(6):1348-1356. PubMed ID: 30805946
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study.
Wiles JR; Isemann B; Mizuno T; Tabangin ME; Ward LP; Akinbi H; Vinks AA
J Pediatr; 2015 Dec; 167(6):1214-20.e3. PubMed ID: 26364984
[TBL] [Abstract][Full Text] [Related]
3. Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients.
McPhail BT; Emoto C; Fukuda T; Butler D; Wiles JR; Akinbi H; Vinks AA
J Clin Pharmacol; 2020 Apr; 60(4):453-465. PubMed ID: 31820437
[TBL] [Abstract][Full Text] [Related]
4. Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.
van Hoogdalem MW; Johnson TN; McPhail BT; Kamatkar S; Wexelblatt SL; Ward LP; Christians U; Akinbi HT; Vinks AA; Mizuno T
Clin Pharmacol Ther; 2022 Feb; 111(2):496-508. PubMed ID: 34679189
[TBL] [Abstract][Full Text] [Related]
5. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
[TBL] [Abstract][Full Text] [Related]
6. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of methadone and its metabolites in neonates, infants, and children.
Ward RM; Drover DR; Hammer GB; Stemland CJ; Kern S; Tristani-Firouzi M; Lugo RA; Satterfield K; Anderson BJ
Paediatr Anaesth; 2014 Jun; 24(6):591-601. PubMed ID: 24666686
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics.
van Hoogdalem MW; McPhail BT; Hahn D; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):87-103. PubMed ID: 33049155
[TBL] [Abstract][Full Text] [Related]
9. Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome.
Dysart K; Hsieh HC; Kaltenbach K; Greenspan JS
J Perinat Med; 2007; 35(4):344-6. PubMed ID: 17511598
[TBL] [Abstract][Full Text] [Related]
10. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*.
Bhatt-Mehta V; Ng CM; Schumacher RE
Pediatr Crit Care Med; 2014 Feb; 15(2):162-9. PubMed ID: 24141658
[TBL] [Abstract][Full Text] [Related]
12. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
Young ME; Hager SJ; Spurlock D
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
[TBL] [Abstract][Full Text] [Related]
13. Opioid neonatal abstinence syndrome: controversies and implications for practice.
Wolff K; Perez-Montejano R
Curr Drug Abuse Rev; 2014; 7(1):44-58. PubMed ID: 25323126
[TBL] [Abstract][Full Text] [Related]
14. The effect of methadone dose regimen on neonatal abstinence syndrome.
McCarthy JJ; Leamon MH; Willits NH; Salo R
J Addict Med; 2015; 9(2):105-10. PubMed ID: 25599433
[TBL] [Abstract][Full Text] [Related]
15. Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing.
Begg EJ; Malpas TJ; Hackett LP; Ilett KF
Br J Clin Pharmacol; 2001 Dec; 52(6):681-5. PubMed ID: 11736879
[TBL] [Abstract][Full Text] [Related]
16. A Novel Perioperative Multidose Methadone-Based Multimodal Analgesic Strategy in Children Achieved Safe and Low Analgesic Blood Methadone Levels Enabling Opioid-Sparing Sustained Analgesia With Minimal Adverse Effects.
Sadhasivam S; Aruldhas BW; Packiasabapathy S; Overholser BR; Zhang P; Zang Y; Renschler JS; Fitzgerald RE; Quinney SK
Anesth Analg; 2021 Aug; 133(2):327-337. PubMed ID: 33481403
[TBL] [Abstract][Full Text] [Related]
17. Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone.
Gaalema DE; Heil SH; Badger GJ; Metayer JS; Johnston AM
Drug Alcohol Depend; 2013 Nov; 133(1):266-9. PubMed ID: 23845658
[TBL] [Abstract][Full Text] [Related]
18. Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates.
Samiee-Zafarghandy S; van Donge T; Allegaert K; van den Anker J
Children (Basel); 2021 Feb; 8(3):. PubMed ID: 33668712
[TBL] [Abstract][Full Text] [Related]
19. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
20. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.
Brogly SB; Saia KA; Walley AY; Du HM; Sebastiani P
Am J Epidemiol; 2014 Oct; 180(7):673-86. PubMed ID: 25150272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
